P-glycoprotein (P-gp) affects the pharmacodynamics of the atypical antipsychotic amisulpride

被引：0
|
作者：
Schmitt, U [1 ]
Härtter, S [1 ]
Hiemke, C [1 ]
机构：
[1] Univ Mainz, D-6500 Mainz, Germany
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [21] Expression of P-glycoprotein (P-gp) in human heart:: Influence of cardiomyopathies and genetics
    Meissner, K
    Karsten, C
    Sperker, B
    Seeland, U
    Böhm, M
    Kunert-Keil, C
    Vogelgesang, S
    Warzok, RW
    Cascorbi, I
    Wendt, M
    Kroemer, HK
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R128 - R128
  • [22] P-GLYCOPROTEIN (P-GP) MEDIATES THE TRANSPORT OF THE CARDIAC GLYCOSIDE, DIGOXIN (DIG)
    DELANNOY, IAM
    SILVERMAN, M
    FASEB JOURNAL, 1993, 7 (03): : A456 - A456
  • [23] Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction Studies
    Elmeliegy, Mohamed
    Vourvahis, Manoli
    Guo, Cen
    Wang, Diane D.
    CLINICAL PHARMACOKINETICS, 2020, 59 (06) : 699 - 714
  • [24] Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: Influence of cell line and modulator concentration on P-GP activity
    Taub, ME
    Podila, L
    Ely, D
    Almeida, I
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (11) : 1679 - 1687
  • [25] Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats
    Suzuki, Kei
    Taniyama, Kazuhiro
    Aoyama, Takao
    Watanabe, Yoshiaki
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (03) : 385 - 392
  • [26] Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats
    Kei Suzuki
    Kazuhiro Taniyama
    Takao Aoyama
    Yoshiaki Watanabe
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 385 - 392
  • [27] Influence of P-glycoprotein (P-gp) induction on the pharmacokinetics of risperidone and paliperidone in mouse brain
    Holthoewer, D.
    Hiemke, C.
    Schmitt, U.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 223 - 223
  • [28] Mibefradil is a potent inhibitor of both CYP3A and P-glycoprotein (P-gp).
    Wandel, C
    Kim, RB
    Guengerich, FP
    Wood, AJJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 124 - 124
  • [29] Relevance of p-glycoprotein (P-gp) and CD34 expression in childhood AML
    vanderHeuvelEibrink, MM
    Boekhorst, PAW
    Schoester, M
    Pieters, R
    vanderHolt, B
    Sonneveld, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1339 - 1339
  • [30] BSP loaded as a high dose is partially excreted into bile by P-glycoprotein (P-GP).
    Takikawa, H
    Sano, N
    Kitaura, K
    Fukumura, S
    Aiso, M
    Uegaki, S
    Akimoto, K
    Sato, A
    Yamanaka, M
    GASTROENTEROLOGY, 1997, 112 (04) : A1395 - A1395
12345